Literature DB >> 11096331

Association study of apolipoprotein E epsilon4 with clinical phenotype and clozapine response in schizophrenia.

C J Hong1, Y W Yu, C H Lin, H L Song, H C Lai, K H Yang, S J Tsai.   

Abstract

Schizophrenic patients with the apolipoprotein E (APOE = gene; apoE = protein) epsilon4 allele exhibited lower psychosis scores than patients without the epsilon4 allele in previous reports. The present study tested the hypothesis that the APOE epsilon4 allele confers association with the clinical manifestations of schizophrenia or clozapine response. A total of 95 schizophrenic patients who were treatment resistant were included in the study. The results demonstrated that the presence of the APOE epsilon4 allele did not influence the response to clozapine in schizophrenic patients, neither was the baseline psychopathology related to the APOE epsilon4 allele. Given the multiple functions of the apoE protein in the brain, further study of the influence of APOE on CNS medication response is needed. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096331     DOI: 10.1159/000026689

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  5 in total

1.  Pharmacogenetics of antipsychotic treatment response and side effects.

Authors:  B Mackenzie; Rp Souza; O Likhodi; Ak Tiwari; Cc Zai; J Sturgess; Dj Müller
Journal:  Therapy       Date:  2010-03

2.  Apolipoprotein E polymorphism is associated with age of onset in schizophrenia.

Authors:  Olli Kampman; Sami Anttila; Ari Illi; Kari M Mattila; Riikka Rontu; Esa Leinonen; Terho Lehtimäki
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

3.  Biological Predictors of Clozapine Response: A Systematic Review.

Authors:  Ruta Samanaite; Amy Gillespie; Kyra-Verena Sendt; Grant McQueen; James H MacCabe; Alice Egerton
Journal:  Front Psychiatry       Date:  2018-07-26       Impact factor: 4.157

4.  Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Authors:  Saeed Mohammad Al-Asmary; Saeed Kadasah; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

5.  Effect of Alzheimer's Disease Risk Variant rs3824968 at SORL1 on Regional Gray Matter Volume and Age-Related Interaction in Adult Lifespan.

Authors:  Chu-Chung Huang; Mu-En Liu; Hung-Wen Kao; Kun-Hsien Chou; Albert C Yang; Ying-Hsiu Wang; Tong-Ru Chen; Shih-Jen Tsai; Ching-Po Lin
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.